NOVO HOLDINGS A/S purchased 16.7% of their position (555.55K shares) of AVALYN PHARMA INC. on the open market

Open‑market purchase worth $10.00M — a significant purchase. The strongest form of insider conviction signal.

P · 1 purchase

NOVO HOLDINGS A/S

Filed: 5/5/2026ACC: 0001388325-26-000021

InsiderNOVO HOLDINGS A/SCIK 1388325

→

IssuerAVALYN PHARMA INC.CIK 1540171

10% Owner

Since Apr 2026

-60.15M

Net shares

Net seller

$10.00M

Total acquired

Open market trades

1B · 0S

Total transactions

3.88M acquired · 64.03M disposed

Non-Derivative Transactions2

Voting Common Stock

Direct

C · Conversion

+3.33M

Price / share

—

Trade value

—

% of position

New position

5/1/2026

0.00→3.33M

Voting Common Stock

Direct

P · Purchase

+555.55K

Price / share

$18.00

Trade value

$10M

% of position

16.7%

5/1/2026

3.33M→3.88M

Total

Net shares

+3.88M

Net value

$10M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Voting Common Stock Direct	5/1/2026	C · Conversion	+3.33M	—	—	New position	0.00	3.33M
Voting Common Stock Direct	5/1/2026	P · Purchase	+555.55K	$18.00	$10M	16.7%	3.33M	3.88M
Total			+3.88M		$10M

Derivative Transactions5

Series A Preferred Stock

Direct

C · Conversion

Converts to

Voting Common Stock

935.47K shares

−18M

Strike price

Held after

0.00

Exercisable

—

5/1/2026

Series B Preferred Stock

Direct

C · Conversion

Converts to

Voting Common Stock

103.23K shares

−1.99M

Strike price

Held after

0.00

Exercisable

—

5/1/2026

Series C-1 Preferred Stock

Direct

C · Conversion

Converts to

Voting Common Stock

1.35M shares

−25.90M

Strike price

Held after

0.00

Exercisable

—

5/1/2026

Series C-2 Preferred Stock

Direct

C · Conversion

Converts to

Voting Common Stock

290.39K shares

−5.59M

Strike price

Held after

0.00

Exercisable

—

5/1/2026

Series D Preferred Stock

Direct

C · Conversion

Converts to

Voting Common Stock

652.65K shares

−12.56M

Strike price

Held after

0.00

Exercisable

—

5/1/2026

Security	Converts To	Date	Type	Shares	Exercisable
Series A Preferred Stock Direct	Voting Common Stock935.47K shares	5/1/2026	C · Conversion	−18M	—
Series B Preferred Stock Direct	Voting Common Stock103.23K shares	5/1/2026	C · Conversion	−1.99M	—
Series C-1 Preferred Stock Direct	Voting Common Stock1.35M shares	5/1/2026	C · Conversion	−25.90M	—
Series C-2 Preferred Stock Direct	Voting Common Stock290.39K shares	5/1/2026	C · Conversion	−5.59M	—
Series D Preferred Stock Direct	Voting Common Stock652.65K shares	5/1/2026	C · Conversion	−12.56M	—